Browsing byAuthor김광명

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
가 나 다 라 마 바 사 아 자 차 카 타 파 하
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 30 of 53

Issue DateTitleAuthor(s)Type
2024Accurately Controlled Tumor Temperature with Silica-Coated Gold Nanorods for Optimal Immune Checkpoint Blockade Therapy김진성; 김광명Article
2025Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapy김광명Article
2023Adoptive Transfer of Photosensitizer-Loaded Cytotoxic T Cells for Combinational Photodynamic Therapy and Cancer Immuno-Therapy김광명Article
2023All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy김광명Article
2026Bioreducible Cu2O cluster-glutathione nanohybrids with multienzyme-mimetic ROS scavenging for cisplatin-induced acute kidney injury김광명Article
2024Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy김진성; 이용현; 김광명Article
2025Cancer-Specific and Pro-Apoptotic PEGylated Liposomes Containing SMAC-Mimetic Doxorubicin Prodrug for Safe High-Dose Delivery in Pancreatic Cancer김광명Article
2023Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy김광명Review
2025Cancer-Specific Doxorubicin Prodrug Enhancing Immune Synergy and Reducing Toxicity in Melanoma Therapy오유정Master's Thesis
2026Cathepsin B-Cleavable Doxorubicin Prodrug Nanoparticles for Eliciting Cancer-Specific Immunogenic Cell Death and Minimizing Systemic Toxicity김진성; 유진하; 김광명Article
2022Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy김광명Article
2025Dual Delivery of Light/Prodrug Nanoparticles Using Tumor-Implantable Micro Light-Emitting Diode on an Optofluidic System for Combinational Glioma Treatment김광명Article
2026Effective Degradation of Wild-Type and Mutant EGFR Using Self-Assembling Peptide-Derived PROTAC Nanoparticles (NanoTACs) for Cancer Therapy김진성; 김광명Article
2024Effective Drug Delivery Strategy for Precise Radio-chemotherapy송선정Master's Thesis
2023Enhanced delivery of the phototherapeutic nanoparticles via hepatocyte overload김광명Article
2026Esterase-responsive albumin-binding PROTACmediated BRD4 degradation for cancer immunotherapy김진성; 김광명Article
2023Fluorescence-Based Mono- and Multimodal Imaging for In Vivo Tracking of Mesenchymal Stem Cells김광명Review
2026High-dose treatment of cathepsin B-activatable doxorubicin prodrug nanoparticles that induce tumor-specific immunogenic cell death for immunotherapy of melanoma with minimal systemic toxicity김진성; 김광명Article
2024High-Dose Treatment of Pro-Apoptotic Doxorubicin Prodrug Liposome for Pancreatic Cancer Therapy김연진Master's Thesis
2022Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light김광명Article
2024Implantable MicroLED-Mediated Chemo-Photodynamic Combination Therapy for Glioma Treatment김진성; 김광명Article
2023In situ albumin-binding and esterase-specifically cleaved BRD4-degrading PROTAC for targeted cancer therapy김광명Article
2023In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity김광명Article
2022Injectable Hydrogel-Based Combination Cancer Immunotherapy for Overcoming Localized Therapeutic Efficacy김광명Review
2023Intracellular Glucose-Depriving Polymer Micelles for Antiglycolytic Cancer Treatment김광명Article
2024Light-Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy김광명Article
2022Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity김광명Article
2026Low-dose radiation generated ROS-activatable doxorubicin prodrug loaded liposome nanoparticles for triple-negative breast cancer treatment김진성; 김광명Article
2024Macropinocytosis-targeted peptide-docetaxel conjugate for bystander pancreatic cancer treatment김광명Article
2022Mesenchymal Stem Cell-Mediated Deep Tumor Delivery of Gold Nanorod for Photothermal Therapy김광명Article

BROWSE